Recent uptick might appease Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) institutional owners after losing 25% over the past year
Yahoo Finance · 24 hours ago
Open | 0.9090 |
High | 1.0000 |
Low | 0.8899 |
Mkt Cap | 2.1B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 0.8611 |
52 Wk. Low | 0.7400 |
52 Wk. High | 2.5450 |
Related stocks
Molecule that encodes the genetic instructions used in the development and functioning of all known living organisms and many viruses
Deoxyribonucleic acid (DNA) is a polymer composed of two polynucleotide chains that coil around each other to form a double helix. The polymer carries genetic instructions for the development, functioning, growth and reproduction of all known organisms and many viruses. DNA and ribonucleic acid (RNA) are nucleic acids. Wikipedia
(USD) | Q4 2023 | Y/Y |
---|---|---|
Revenue | 34.76M | 64.60% ▼ |
Net Income | -211.69M | - |
Diluted EPS | -0.11 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q1 2024 | -$0.08 | - |
Q4 2023 | -$0.10 | -$0.11 |
Q3 2023 | -$0.09 | -$0.16 |
S&P FuturesES=F | 5,174.00+19.25 (+0.37%) |
Dow FuturesYM=F | 38,974.00+142.00 (+0.37%) |
Nasdaq FuturesNQ=F | 18,057.00+56.25 (+0.31%) |
23.33+3.46% | |
113.66+0.92% | |
1,223.01+8.29% |